Preventing and Addressing Chronic Disease. Tim Nikolai, Sr. Community Health Director

Size: px
Start display at page:

Download "Preventing and Addressing Chronic Disease. Tim Nikolai, Sr. Community Health Director"

Transcription

1 Preventing and Addressing Chronic Disease Tim Nikolai, Sr. Community Health Director

2 Disclosures I have no actual or potential conflict of interests involving the materials in this presentation.

3 &

4 Target: BP A national initiative to improve blood pressure control

5 What is Target: BP? A call to action motivating medical practices, practitioners and health services organizations to prioritize blood pressure control. Recognition for healthcare providers who attain high levels of blood pressure control in their patient populations, particularly those who achieve 70, 80 percent or higher control A source for tools and assets for healthcare providers to use in practice, including the AHA/ACC/CDC Hypertension Treatment Algorithm and the AMA s M.A.P. Checklist targetbp.org

6 Hypertension control rate is both a measure of and catalyst for better cardiovascular health.

7 The American Heart Association & American College of Cardiology have updated the guidelines for hypertension control. Notably, the guidelines eliminate the diagnosis of pre-hypertension and identifies anything greater than 130 or 80 as Stage 1 hypertension. Heart disease and stroke risk is doubled at 130/80 compared to blood pressure below 120/ million American adults have hypertension and approximately 46% are uncontrolled.

8 Hypertension rates by gender and ethnicity. 8

9 Top 5 Takeaways from new HTN Guidelines 1. Classification of Blood Pressure: Four new BP categories based on the average of two or more in-office blood pressure readings. 2. Prevalence of High Blood Pressure: Substantially higher prevalence of HTN under the new guideline, 46% of U.S. adults vs 32%, based on JNC Treatment of High Blood Pressure: All patients with blood pressures > normal should utilize nonpharmacological interventions. Use of BPlowering medications is recommended based on stage of HTN, individual medical history or est. CVD risk 10% using the ACC/AHA Risk Estimator. 4. Blood Pressure Goal for people with High Blood Pressure: For adults with confirmed hypertension and known CVD, or 10-year ASCVD event risk of 10% or higher, a BP goal of less than 130/80 mm Hg is recommended. 5. Use Self-measured Blood Pressure Monitoring (SMBP) to Diagnose, Reassess, and Activate Patients with High Blood Pressure. 9

10 The M.A.P. Algorithm targetbp.org

11 Impact of MAP Algorithm Greenville SC Clinic Resource limited clinic 50% African American and 50% Medicare population 6 month study of about 714 hypertensive patients with at least one visit (70+ % had 2 visits and 49% had three visits Control rate for those who visited at least once during the study increased by 28 pts from 61 to 89 pts

12 Data Submission Information

13 Target: BP and Your System/Practice Register at to gain full access to materials, webinars, etc. Data submission is required for recognition and includes: - Total adult patient population and that with HTN (total and controlled) - Adult population by age, gender and ethnicity for the Million Hearts prevalence estimator. The data submission window for 2017 data (still based on NQF #0018) is February 5 th through June 1 st. targetbp.org

14 Wisconsin s 2017 Target: BP Awardees Congratulations to All Saints Family Health Center City of Milwaukee Health Dept. Northern Health Centers, Inc. ThedaCare Milwaukee Milwaukee Lakewood Appleton Bellin Health Divine Savior Healthcare St. Ann Center for Intergenerational Care Green Bay Portage Milwaukee targetbp.org 14

15 An overview of the AHA initiative to help physicians 2018 Recognition Program and patients control cholesterol.

16 Program Overview Check. Change. Control. Cholesterol is a national initiative sponsored by Sanofi and Regeneron to bring Cholesterol management to the attention of patients and providers. High Cholesterol is a major risk factor for cardiovascular disease and stroke, the No. 1 and No. 5 killers in the U.S. This initiative aims to improve awareness, detection and management of high cholesterol by educating and empowering consumers, healthcare professionals and patients with evidence-based information and tools, while also improving quality of care for patients through AHA s quality improvement program.

17 Cholesterol Guidelines The 2013 ACC/AHA Prevention Guideline shifted from treatment to a target LDL cholesterol goal to treatment based on 10-year risk of having an atherosclerotic cardiovascular disease (ASCVD) or stroke event: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk Goff, Circulation (2013) 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults Stone, Circulation (2013)

18 ASCVD Risk Calculator The ASCVD risk calculator is an evidence-based tool that was developed together for the 2013 Cholesterol Guidelines. The risk calculator assesses risk for having a first time cardiovascular or stroke event in the next 10 years A risk of 7.5% or greater should prompt providers and patients to discuss lifestyle changes and further treatment options (e.g., statin prescription) Online tools are available for providers and patients to estimate 10-year risk: ASCVD Risk Estimator (provider tool) Check. Change. Control. Calculator (patient tool).

19 Patient Calculator Provider Calculator

20 ASCVD Risk Calculator Why Use the ASCVD Risk Calculator? The ASCVD Risk calculator is an evidence-based tool for assessing baseline 10-year risk of having a first ASCVD event. The calculator can help inform the patient-provider discussion on lifestyle changes and incorporating medications (e.g., statins) to improve cholesterol control and reduce cardiovascular risk. The ASCVD risk calculator was included in the 2017 High Blood Pressure Clinical Practice Guideline as a component in treatment decision-making for patients with Stage 1 Hypertension. Additional tools have been developed to estimate the potential impact of Aspirin therapy in appropriate patients, Blood pressure control, Cholesterol management, and Smoking cessation (ABCS).

21 2018 Check. Change. Control. Cholesterol Recognition Program

22 Why should providers join Check. Change. Control. Cholesterol? Provider tool kit Patient tool kit Support through AHA field staff Part 4 Maintenance of Certification for providers / continuing education Patient and provider ASCVD Risk Calculators Local and national recognition

23 How does a site register? Go to heart.org/changecholesterol 1. Register (required to access materials/always open) By June 1 st 2. Achievement Award (opt.) 3. Gold Award (optional)

24 THERE ARE THREE SUBMISSION CRITERIA FOR MIPS 438 DENOMINATOR (SUBMISSION CRITERIA) 1) Patients aged 21 years at the beginning of the measurement period with clinical ASCVD diagnosis OR 2) Patients aged 21 years at the beginning of the measurement period who have ever had a fasting or direct laboratory result of LDL-C 190 mg/dl or were previously diagnosed with or currently have an active diagnosis of familial or pure hypercholesterolemia OR 3) Patients aged 40 to 75 years at the beginning of the measurement period with Type 1 or Type 2 diabetes and with an LDL-C result of mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period NUMERATOR (SUBMISSION CRITERIA): 1) Patients who are actively using or who receive an order (prescription) for statin therapy at any point during the measurement period

25 How are sites recognized for their achievements? Listed on CCC Cholesterol website National recognition at AHA Scientific Sessions in 2018 Certificate can be delivered electronically and displayed within practice for both Participation and Gold levels Icon badge with AHA proclaimer statement to use internally and externally on webpages and social media Local press release template for clinics Local recognition opportunities

26 How you can help! - Share information/resources with your colleagues in ambulatory care/ clinic management - Offer assistance with data abstraction for hypertension control/statin use. - Celebrate existing success!

27 Questions? Tim Nikolai

Welcome to the New England QIN-QIO Webinar!

Welcome to the New England QIN-QIO Webinar! Welcome to the New England QIN-QIO Webinar! Thank you for joining. Our presentation will begin shortly. If you haven t already, please dial in to the audio line: 888-895-6448 Passcode: 519-6001 Slides

More information

Target: BP Overview with Lake Superior QIN Wednesday, February 22, :00 PM 1:00 PM CST

Target: BP Overview with Lake Superior QIN Wednesday, February 22, :00 PM 1:00 PM CST Target: BP Overview with Lake Superior QIN Wednesday, February 22, 2017 12:00 PM 1:00 PM CST Presenters American Heart Association Stefanie Worth, Senior Community Health Director, Michigan Sueling Schardin,

More information

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD)

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD) Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD) 2. Welcome by Stacey Sheridan, MD, MPH Hello. My name is Stacey Sheridan, and I m here as your partner in Heart Health Now. The North

More information

November 9, 2018 Karen Kmetik, PhD Group Vice President, Improving Health Outcomes

November 9, 2018 Karen Kmetik, PhD Group Vice President, Improving Health Outcomes AMA Academic Physicians Section Improving Health Outcomes Update November 9, 2018 Karen Kmetik, PhD Group Vice President, Improving Health Outcomes 1 The urgency: The national numbers are large and growing

More information

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary 2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth

More information

Treating Hypertension in 2018: What Makes the Most Sense Today?

Treating Hypertension in 2018: What Makes the Most Sense Today? Treating Hypertension in 2018: What Makes the Most Sense Today? Daniel Blanchard, MD Professor of Medicine UC San Diego Cardiovascular Center La Jolla, California 1 2 Speaker Disclosures Consultant and/or

More information

Measure Up / Pressure Down: Improving Blood Pressure Control in Washington, DC

Measure Up / Pressure Down: Improving Blood Pressure Control in Washington, DC Measure Up / Pressure Down: Improving Blood Pressure Control in Washington, DC IHI 15 th Annual International Summit on Improving Patient Care in the Office Practice and the Community Peter Basch, MD,

More information

Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care

Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care Quality ID #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

TAKING THE PULSE: Support for Improving Blood Pressure Measurement & Management

TAKING THE PULSE: Support for Improving Blood Pressure Measurement & Management WELCOME TO TAKING THE PULSE: Support for Improving Blood Pressure Measurement & Management February 26, 2018 Thank you for joining us! The session will begin shortly. Webinar from Washington Association

More information

Update on New RCHC Relevant and BridgeIT Reports. Redwood Community Health Coalition Data Group Webinar November 13, 2018 By Ben Fouts, Data Analyst

Update on New RCHC Relevant and BridgeIT Reports. Redwood Community Health Coalition Data Group Webinar November 13, 2018 By Ben Fouts, Data Analyst Update on New RCHC Relevant and BridgeIT Reports Redwood Community Health Coalition Data Group Webinar November 13, 2018 By Ben Fouts, Data Analyst Agenda New Measures (2019) UDS: CAD QIP: Asthma Medication

More information

Using the New Hypertension Guidelines

Using the New Hypertension Guidelines Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in

More information

CONTRIBUTING FACTORS FOR STROKE:

CONTRIBUTING FACTORS FOR STROKE: CONTRIBUTING FACTORS FOR STROKE: HYPERTENSION AND HYPERCHOLESTEROLEMIA Melissa R. Stephens, MD, FAAFP Associate Professor of Clinical Sciences William Carey University College of Osteopathic Medicine LEARNING

More information

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for

4/7/ The stats on heart disease. + Deaths & Age-Adjusted Death Rates for + Update on Lipid Management Stacey Gardiner, MD Assistant Professor Division of Cardiovascular Medicine Medical College of Wisconsin + The stats on heart disease Over the past 10 years for which statistics

More information

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines

Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Update on Lipid Management in Cardiovascular Disease: How to Understand and Implement the New ACC/AHA Guidelines Paul Mahoney, MD Sentara Cardiology Specialists Lipid Management in Cardiovascular Disease

More information

Atherosclerotic Disease Risk Score

Atherosclerotic Disease Risk Score Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,

More information

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):

More information

Prevention Updates and Paradigm Shifts

Prevention Updates and Paradigm Shifts Prevention Updates and Paradigm Shifts Andrew Freeman, MD, FACC Director of Clinical Cardiology and Operations National Jewish Health Assistant Professor of Medicine National Jewish Health and University

More information

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines Conflict of Interest Disclosure Updates for the Ambulatory Care Pharmacist: Dyslipidemia and CV Risk Assessment No conflicts of interest to disclose 2014 Updates to the Updates in Ambulatory Care Pharmacy

More information

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series

Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series Our speaker today is: Susan Vos, BSN, RN, CCM Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series We will be starting shortly A few housekeeping items: We will be

More information

Lipid Management 2013 Statin Benefit Groups

Lipid Management 2013 Statin Benefit Groups Clinical Integration Steering Committee Clinical Integration Chronic Disease Management Work Group Lipid Management 2013 Statin Benefit Groups Approved by Board Chair Signature Name (Please Print) Date

More information

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner 2011 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current

More information

Managing Cholesterol and Pursuing a Healthier Lifestyle September 23, :00pm - 2:00pm CT

Managing Cholesterol and Pursuing a Healthier Lifestyle September 23, :00pm - 2:00pm CT Managing Cholesterol and Pursuing a Healthier Lifestyle September 23, 2015 1:00pm - 2:00pm CT Welcome & Introductions Million Hearts Description of the ABCS John M. Clymer, Executive Director National

More information

= AUDIO. Managing Diabetes for Improved Cardiovascular Health. An Important Reminder. Mission of OFMQ 8/18/2015. Jimmi Norris MS, RN, CDE

= AUDIO. Managing Diabetes for Improved Cardiovascular Health. An Important Reminder. Mission of OFMQ 8/18/2015. Jimmi Norris MS, RN, CDE Managing Diabetes for Improved Cardiovascular Health Jimmi Norris MS, RN, CDE An Important Reminder For audio, you must use your phone: Step 1: Call (866) 906 0123. Step 2: Enter code 2071585#. Step 3:

More information

NEW GUIDELINES FOR CHOLESTEROL

NEW GUIDELINES FOR CHOLESTEROL NEW GUIDELINES FOR CHOLESTEROL NEW CHOLESTEROL GUIDELINES 2013 Recently updated guidelines for the treatment of high blood cholesterol levels is a major update since 2002. The news media have trumpeted

More information

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools.

9/18/2017 DISCLOSURES. Consultant: RubiconMD. Research: Amgen, NHLBI OUTLINE OBJECTIVES. Review current CV risk assessment tools. UW MEDICINE UW MEDICINE UCSF ASIAN TITLE HEALTH OR EVENT SYMPOSIUM 2017 DISCLOSURES Consultant: RubiconMD ESTIMATING CV RISK IN ASIAN AMERICANS AND PREVENTION OF CVD Research: Amgen, NHLBI EUGENE YANG,

More information

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials PREVENTING CARDIOVASCULAR DISEASE IN WOMEN: Current Guidelines for Hypertension, Lipids and Aspirin Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial

More information

HEALTHCARE REFORM. September 2012

HEALTHCARE REFORM. September 2012 HEALTHCARE REFORM Accountable Care Organizations: ACOs 101 September 2012 The enclosed slides are intended to provide you with a general overview of accountable care organizations (ACOs), created within

More information

3/19/2015. Million Hearts : An Exemplary Platform for Teaching Interprofessional Practice & Population Health in Advanced Practice Nursing Curricula

3/19/2015. Million Hearts : An Exemplary Platform for Teaching Interprofessional Practice & Population Health in Advanced Practice Nursing Curricula Million Hearts : An Exemplary Platform for Teaching Interprofessional Practice & Population Health in Advanced Practice Nursing Curricula Presenters Alice Teall MS, RN, FNP/PNP, FAANP Kate Gawlik, MS,

More information

Developing a QAPI Program for Cardiovascular Health Improvement

Developing a QAPI Program for Cardiovascular Health Improvement Developing a QAPI Program for Cardiovascular Health Improvement Ashley Green MetaStar WiAHC Annual Conference November 5 th, 2015 Objectives The audience will be able to: Describe the purpose of HHQI s

More information

Preventing 1 Million Heart Attacks and Strokes by 2022

Preventing 1 Million Heart Attacks and Strokes by 2022 Preventing 1 Million Heart Attacks and Strokes by 2022 Miriam Patanian, MPH Senior Consultant for Health Systems and Cardiovascular Health National Association of Chronic Disease Directors Million Hearts

More information

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment

More information

Cholesterol Guidelines Calculator

Cholesterol Guidelines Calculator Cholesterol Guidelines Calculator 1 / 6 2 / 6 3 / 6 Cholesterol Guidelines Calculator Calculate your 10-year risk of heart disease or stroke using the ASCVD algorithm published in 2013 ACC/AHA Guideline

More information

5. Cardiovascular Disease & Stroke

5. Cardiovascular Disease & Stroke 5. Cardiovascular Disease & Stroke 64: Self-Reported Heart Disease 66: Heart Disease Management 68: Heart Disease Mortality 70: Heart Disease Mortality Across Life Span 72: Stroke Mortality 185: Map 3:

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pokharel Y, Tang F, Jones PG, et al. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in cardiology practices

More information

Hypertension and Cholesterol in the Elderly

Hypertension and Cholesterol in the Elderly Hypertension and Cholesterol in the Elderly Angela Sanford, MD Assistant Professor of Geriatrics Saint Louis University School of Medicine I have no relevant financial disclosures Cushman WC. The burden

More information

Blood Pressure LIMBO How Low To Go?

Blood Pressure LIMBO How Low To Go? Blood Pressure LIMBO How Low To Go? Joseph L. Kummer, MD, FACC Bryan Heart Spring Conference April 21 st, 2018 Hypertension Epidemiology Over a billion people have hypertension Major cause of morbidity

More information

Getting to the Heart of the Matter: Hypertension and The Million Hearts Initiative

Getting to the Heart of the Matter: Hypertension and The Million Hearts Initiative Click to edit Master title style Getting to the Heart of the Matter: Hypertension and The Million Hearts Initiative Laura Rappleye, Bruce Maki & Teri Wilson (MDCH) M-CEITA / Altarum Institute April 16,

More information

BACKGROUND: Formal networks of practices are well-established platforms for learning and sharing pragmatic lessons about clinical practice to improve

BACKGROUND: Formal networks of practices are well-established platforms for learning and sharing pragmatic lessons about clinical practice to improve BACKGROUND: Formal networks of practices are well-established platforms for learning and sharing pragmatic lessons about clinical practice to improve patient care. Among network practices, clinical quality

More information

Donna Amundson, RN, BSN, CDE Director of the Sanford Diabetes Center Bismarck, ND

Donna Amundson, RN, BSN, CDE Director of the Sanford Diabetes Center Bismarck, ND Donna Amundson, RN, BSN, CDE Director of the Sanford Diabetes Center Bismarck, ND Discuss the core principles of quality management for diabetes care and education Identify the 6 core elements of the Chronic

More information

Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice

Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice Lipid Management: The Next Level How Will the New ACC/AHA Guidelines Change My Practice Vera Bittner, MD, MSPH Professor of Medicine Section Head, Preventive Cardiology Medical Director, Cardiac Rehabilitation

More information

Cardiovascular Controversies: Exploring the ACC and AHA Guidelines on the Treatment of Blood Cholesterol

Cardiovascular Controversies: Exploring the ACC and AHA Guidelines on the Treatment of Blood Cholesterol Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW CONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN CONARY ARTERY DISEASE (CAD) MEASURES GROUP: #6. Coronary Artery Disease (CAD): Antiplatelet

More information

Measure Up Pressure Down. Scott Flinn MD Fritz Steen RN

Measure Up Pressure Down. Scott Flinn MD Fritz Steen RN Measure Up Pressure Down Scott Flinn MD Fritz Steen RN Arch Health Partners AHP is a 1206 (l) Medical Foundation and 501(c)3 Community Benefit organization formed by Palomar Pomerado Health and Centre

More information

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD Current Cholesterol Guidelines and Treatment of Residual Risk J. Peter Oettgen, MD Associate Professor of Medicine Harvard Medical School Director, Preventive Cardiology Beth Israel Deaconess Medical Center

More information

2017 MSSP Clinical Quality Measures

2017 MSSP Clinical Quality Measures *The information contained in this document relies heavily on information supplied by CMS. GPRO CARE-1 (NQF 0097): Medication Reconciliation Post-Discharge DESCRIPTION: Percentage of discharges from any

More information

CMMI Project: San Diego A Heart Attack and Stroke Free Zone. Parag Agnihotri, MD Chair of the Healthcare Committee

CMMI Project: San Diego A Heart Attack and Stroke Free Zone. Parag Agnihotri, MD Chair of the Healthcare Committee CMMI Project: San Diego A Heart Attack and Stroke Free Zone Parag Agnihotri, MD Chair of the Healthcare Committee San Diego: A Heart Attack and Stroke Free Zone Goal Reduce heart attacks and strokes by

More information

Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly

Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly Paul Muntner, PhD MHS Professor and Vice Chair Department of Epidemiology University of Alabama

More information

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Management of Lipid Disorders and Hypertension Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine

More information

2017 High Blood Pressure Clinical Practice Guideline

2017 High Blood Pressure Clinical Practice Guideline 2017 High Blood Pressure Clinical Practice Guideline Applying the Latest Hypertension Guideline to Your Practice Carmine D Amico, D.O., F.A.C.C. 2017 ACC / AHA / AAPA / ABC / ACPM / AGS / APhA / ASH /

More information

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant

More information

2. Measurement Specifications 3. Patient Messaging 4. Provider Messaging Other Recent Guidelines

2. Measurement Specifications 3. Patient Messaging 4. Provider Messaging Other Recent Guidelines Measure Up/Pressure Down Response to the Release of 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report from the Panel Members Appointed to the Eighth Joint National

More information

Disclosure. I have no relevant financial relationships with commercial interests to disclose American Medical Association. All rights reserved.

Disclosure. I have no relevant financial relationships with commercial interests to disclose American Medical Association. All rights reserved. Disclosure I have no relevant financial relationships with commercial interests to disclose. 2 Objectives Describe the trends in type 2 diabetes and implications for clinical practice Review the evidence

More information

2/10/2016. Perspectives on the 2013 ACC/AHA Cholesterol Guidelines. Disclosures. ATP-III Update 2004

2/10/2016. Perspectives on the 2013 ACC/AHA Cholesterol Guidelines. Disclosures. ATP-III Update 2004 Perspectives on the 2013 ACC/AHA Cholesterol Guidelines Donald M. Lloyd-Jones, MD ScM Senior Associate Dean Chair and Professor of Preventive Medicine Northwestern Feinberg School of Medicine Disclosures

More information

Aha blood pressure guidelines 2016 chart. Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu

Aha blood pressure guidelines 2016 chart. Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu Search for: Search Search Aha blood pressure guidelines 2016 chart Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu 10-2-2012 Here we explain what blood pressure is, how it is measured, and

More information

Modern Lipid Management:

Modern Lipid Management: Modern Lipid Management: New Drugs, New Targets, New Hope Kirk U. Knowlton, M.D Director of Cardiovascular Research Co Chief of Cardiology Why lower LDL C in those without evidence of CAD (primary prevention)

More information

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0 Consensus Core Set: ACO and PCMH / Primary Care s 0018 Controlling High Blood Pressure patients 18 to 85 years of age who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately

More information

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease

More information

Sanger Heart & Vascular Institute Symposium 2015

Sanger Heart & Vascular Institute Symposium 2015 Sanger Heart & Vascular Institute Symposium 2015 Cardiovascular Update For Primary Care Physicians William E. Downey, MD FACC FSCAI Medical Director, Interventional Cardiology Sanger Heart & Vascular Institute

More information

2/11/2019 CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES DUALITY OF INTEREST

2/11/2019 CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES DUALITY OF INTEREST CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES George L. Bakris, M.D.,F.A.S.N., F.A.H.A. Professor of Medicine Director, Am Heart Assoc. Comprehensive Hypertension Center University of Chicago Medicine

More information

2014/10/20. Management of Lipid Disorders Eric Klug Sunninghill, Sunward Park and CM JHB Academic Hospitals

2014/10/20. Management of Lipid Disorders Eric Klug Sunninghill, Sunward Park and CM JHB Academic Hospitals Management of Lipid Disorders Eric Klug Sunninghill, Sunward Park and CM JHB Academic Hospitals Sudden and unexpected deaths in an adult population, Cape Town, South Africa, 2001-2005 1 Sudden and unexpected

More information

4 th and Goal To Go How Low Should We Go? :

4 th and Goal To Go How Low Should We Go? : 4 th and Goal To Go How Low Should We Go? : Evaluating New Lipid Lowering Therapies Catherine Bourg Rebitch, PharmD, BCACP Clinical Associate Professor Disclosure The presenter has nothing to disclose

More information

ASSESS AND ADDRESS RISK OF CARDIOVASCULAR DISEASE

ASSESS AND ADDRESS RISK OF CARDIOVASCULAR DISEASE ASSESS AND ADDRESS RISK OF CARDIOVASCULAR DISEASE Heart diseases and stroke are the top causes of death and disability among people with Type 2 diabetes. In fact, at least 65 percent of people with diabetes

More information

Study 1 ( ) Pivotal Phase 3 Long-Term Safety Study Top-Line Results

Study 1 ( ) Pivotal Phase 3 Long-Term Safety Study Top-Line Results Study 1 (1002-040) Pivotal Phase 3 Long-Term Safety Study Top-Line Results May 2, 2018 1 COPYRIGHT 2018 ESPERION. ALL RIGHTS RESERVED DO NOT COPY OR DISTRIBUTE Safe Harbor Forward-Looking Statements These

More information

Diagnosis and Management of Type 2 Diabetes Mellitus in Adults

Diagnosis and Management of Type 2 Diabetes Mellitus in Adults Quality Improvement Support: Diagnosis and Management of Type 2 Diabetes Mellitus in Adults The Aims and Measures section is intended to provide guideline users with a menu of measures for multiple purposes,

More information

When Statins Aren t Enough: Appropriate Therapies for High-Risk Patients with Diabetes

When Statins Aren t Enough: Appropriate Therapies for High-Risk Patients with Diabetes When Statins Aren t Enough: Appropriate Therapies for High-Risk Patients with Diabetes Kim K. Birtcher, MS, PharmD, AACC, FNLA, CLS, BCPS (AQ-Cardiology), CDE Clinical Professor University of Houston College

More information

What s In the New Hypertension Guidelines?

What s In the New Hypertension Guidelines? American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the

More information

What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline?

What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline? What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline? Salim S. Virani, MD, PhD, FACC, FAHA Associate Professor, Section of Cardiovascular Research Baylor

More information

NQF Members NQF Staff Voting Draft Report: NQF-Endorsed Measures for Cardiovascular DA: October 17, 2016

NQF Members NQF Staff Voting Draft Report: NQF-Endorsed Measures for Cardiovascular DA: October 17, 2016 Memo TO: FR: RE: NQF Members NQF Staff Voting Draft Report: NQF-Endorsed Measures for Cardiovascular DA: October 17, 2016 Background Phase 4 of this project, the 24-member Cardiovascular Standing Committee

More information

No relevant financial relationships

No relevant financial relationships MANAGEMENT OF LIPID DISORDERS Balancing Benefits and harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial relationships baron@medicine.ucsf.edu

More information

Primary Stroke Center Quality & Performance Measures

Primary Stroke Center Quality & Performance Measures Primary Stroke Center Quality & Performance Measures This section of the manual contains information related to the quality performance of Primary Stroke Centers. Brain Attack Coalition Definitions Recognition

More information

Cholesterol Management Roy Gandolfi, MD

Cholesterol Management Roy Gandolfi, MD Cholesterol Management 2017 Roy Gandolfi, MD Goals Interpreting cholesterol guidelines Cholesterol treatment in diabetics Statin use and side effects therapy Reporting- Comparison data among physicians

More information

2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members

2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members 2017 Diabetes Program Evaluation Our mission is to improve the health and quality of life of our members Diabetes Program Evaluation Program Title: Diabetes Program Evaluation Period: January 1, 2017 December

More information

2013 ACC AHA LIPID GUIDELINE JAY S. FONTE, MD

2013 ACC AHA LIPID GUIDELINE JAY S. FONTE, MD 2013 ACC AHA LIPID GUIDELINE JAY S. FONTE, MD How do you interpret my blood test results? What are our targets for these tests? Before the ACC/AHA Lipid Guidelines A1c:

More information

Diabetes Care Begins With Diabetes Prevention

Diabetes Care Begins With Diabetes Prevention Diabetes Care Begins With Diabetes Prevention Noah Nesin, M.D., FAAFP June 28, 2018 12-1pm Webinar Logistics for Zoom Audio lines for non-presenters are currently muted Please use the Q & A function for

More information

Implementation of JNC- 8 Hypertension Recommendations: Combining evidence and value-based practice strategies for accountable care

Implementation of JNC- 8 Hypertension Recommendations: Combining evidence and value-based practice strategies for accountable care Implementation of JNC- 8 Hypertension Recommendations: Combining evidence and value-based practice strategies for accountable care Shari Bolen MD, MPH MetroHealth/Case Western Reserve University 1 Disclosure

More information

Diabetes MAYER B. DAVIDSON, MD,* CO-EDITOR-IN-CHIEF; HENRY N. GINSBERG, MD, REVIEWER; TERRENCE F. FAGAN, MANAGING EDITOR; CHING-LING CHEN, PhD, WRITER

Diabetes MAYER B. DAVIDSON, MD,* CO-EDITOR-IN-CHIEF; HENRY N. GINSBERG, MD, REVIEWER; TERRENCE F. FAGAN, MANAGING EDITOR; CHING-LING CHEN, PhD, WRITER Professional Postgraduate Services Release Date: March 14, 2008 Valid Through: July 14, 2008 Sponsor This educational activity is a component of the National Diabetes Education Initiative (NDEI ), sponsored

More information

Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s

Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s Ho Chi Minh City, Vietnam August 7, 2014 JBS 2 Risk Guidelines (2005) Based

More information

The New Hypertension Guidelines

The New Hypertension Guidelines The New Hypertension Guidelines Joseph Saseen, PharmD Professor and Vice Chair, Department of Clinical Pharmacy University of Colorado Anschutz Medical Campus Disclosure Joseph Saseen reports no conflicts

More information

Medicare Shared Savings Program Accountable Care Organization (ACO) Measure Deep Dive Series

Medicare Shared Savings Program Accountable Care Organization (ACO) Measure Deep Dive Series Medicare Shared Savings Program Accountable Care Organization (ACO) Measure Deep Dive Series Preventive Care and Screening (Prev-13) Measure 42 Statin Therapy for the Prevention and Treatment of Cardiovascular

More information

Meaningful Use & Million Hearts. Improving Cardiovascular Disease & Stroke Through Quality Measurements

Meaningful Use & Million Hearts. Improving Cardiovascular Disease & Stroke Through Quality Measurements Meaningful Use & Million Hearts Improving Cardiovascular Disease & Stroke Through Quality Measurements Phone lines are now muted Find this or any previous webinar, go to http://www.ehrhelp.missouri.edu

More information

Managing Hypertension in 2018

Managing Hypertension in 2018 MANAGING HYPERTENSION IN 2018 How Do We Work With Conflicting Data and Conflicting Guidelines? Disclosure No relevant financial relationships Robert B. Baron, MD MS Professor and Associate Dean UCSF School

More information

Best Practices in Cardiac Care: Getting with the Guidelines

Best Practices in Cardiac Care: Getting with the Guidelines Best Practices in Cardiac Care: Getting with the Guidelines December 9, 2014 Agenda Cardiovascular Disease: How do the guidelines fit into an implementation scheme? What the guidelines set out to accomplish

More information

Novel PCSK9 Outcomes. in Perspective: Lessons from FOURIER & ODYSSEY LDL-C. ASCVD Risk. Suboptimal Statin Therapy

Novel PCSK9 Outcomes. in Perspective: Lessons from FOURIER & ODYSSEY LDL-C. ASCVD Risk. Suboptimal Statin Therapy LDL-C Novel PCSK9 Outcomes Suboptimal Statin Therapy ASCVD Risk in Perspective: Lessons from FOURIER & ODYSSEY Jennifer G. Robinson, MD, MPH Professor, Departments of Epidemiology & Medicine Director,

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:

More information

Health Care Systems Research Network (HCSRN) Conference April 12, 2018 Minneapolis, MN

Health Care Systems Research Network (HCSRN) Conference April 12, 2018 Minneapolis, MN Health Care Systems Research Network (HCSRN) Conference April 12, 2018 Minneapolis, MN Impact of the Latest USPSTF Recommendations for Statin Use for Primary Cardiovascular Prevention on Payers and Care

More information

HYPERLIPIDEMIA IN THE OLDER POPULATION NICOLE SLATER, PHARMD, BCACP AUBURN UNIVERSITY, HARRISON SCHOOL OF PHARMACY JULY 16, 2016

HYPERLIPIDEMIA IN THE OLDER POPULATION NICOLE SLATER, PHARMD, BCACP AUBURN UNIVERSITY, HARRISON SCHOOL OF PHARMACY JULY 16, 2016 HYPERLIPIDEMIA IN THE OLDER POPULATION NICOLE SLATER, PHARMD, BCACP AUBURN UNIVERSITY, HARRISON SCHOOL OF PHARMACY JULY 16, 2016 NOTHING TO DISCLOSE I, Nicole Slater, have no actual or potential conflict

More information

New Guidelines in Dyslipidemia Management

New Guidelines in Dyslipidemia Management The Fourth IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk Muscat, Oman, February 2018 New Guidelines in Dyslipidemia Management Dr. Khalid Al-Waili, MD, FRCPC, DABCL Senior Consultant Medical

More information

Hypertension Guidelines 2017

Hypertension Guidelines 2017 Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,

More information

To fully participate in this session: Please obtain a Framingham Risk Calculator google: My Health Alberta Risk Calculator click: Heart Disease Risk

To fully participate in this session: Please obtain a Framingham Risk Calculator google: My Health Alberta Risk Calculator click: Heart Disease Risk To fully participate in this session: Please obtain a Framingham Risk Calculator google: My Health Alberta Risk Calculator click: Heart Disease Risk Calculator Worksite Screening and the Unknown Burden

More information

HYPERTENSION: ARE WE GOING TOO LOW?

HYPERTENSION: ARE WE GOING TOO LOW? HYPERTENSION: ARE WE GOING TOO LOW? George L. Bakris, M.D.,F.A.S.N.,F.A.S.H., F.A.H.A. Professor of Medicine Director, ASH Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL USA

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor

More information

Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation. Hot Off the Press and into Your Practice: The Last Year in Medical News

Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation. Hot Off the Press and into Your Practice: The Last Year in Medical News Hot Off the Press and into Your Practice: The Last Year in Medical News Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Moyer VA, et al. Ann Internal Med. 2014;160(5):330-338.

More information

Preventive Cardiology Scientific evidence

Preventive Cardiology Scientific evidence Preventive Cardiology Scientific evidence Professor David A Wood Garfield Weston Professor of Cardiovascular Medicine International Centre for Circulatory Health Imperial College London Primary prevention

More information

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer

More information

Update in Cardiology Pharmacologic Management of Cardiovascular Risk. Christopher C. Roe, MSN, ACNP

Update in Cardiology Pharmacologic Management of Cardiovascular Risk. Christopher C. Roe, MSN, ACNP Update in Cardiology Pharmacologic Management of Cardiovascular Risk Christopher C. Roe, MSN, ACNP Objectives 1. Verbalize understanding of new pharmacologic guidelines in the treatment of hypertension

More information

2017 CMS Web Interface Reporting

2017 CMS Web Interface Reporting 2017 CMS Web Interface Reporting Keys to Successful Reporting Part 2 Measures Refresher November 27, 2017 1:30 3:00 p.m. ET Sherry Grund, Telligen Mary Schrader, Telligen Medicare Shared Savings Program

More information

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July

More information

Check. Change. Control. Connecting Communities and Care

Check. Change. Control. Connecting Communities and Care Check. Change. Control. Connecting Communities and Care Background Check It. Change It. Check It. Change It.* launched in Durham County, N.C. to help a targeted group (~76% African-American) maintain healthy

More information

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA Senior Associate Dean Chair, Department of Preventive

More information

Brent M. Egan, MD Professor of Medicine USCSOM Greenville

Brent M. Egan, MD Professor of Medicine USCSOM Greenville Contemporary Management of Uncontrolled and Treatment Resistant Hypertension Brent M. Egan, MD Professor of Medicine USCSOM Greenville Disclosures (past 3 years): Honoraria: BCBSSC, Medtronic Grant Support:

More information